No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Induction chemotherapy with docetaxel, cisplatin, and cetuximab offers similar outcomes with a potentially more favorable treatment schedule than 5-fluorouracil

byTeddy Guo

October 14, 2021

in StudyGraphics

Reading Time: 1 min read

Click to read this study in the European Journal of Cancer.

RELATED REPORTS

Expanding human papillomavirus vaccination to high-risk mid-adults may be cost-effective

Radiotherapy with cetuximab or durvalumab for advanced HNSCC

Pembrolizumab with chemoradiotherapy improves survival in locally advanced cervical cancer

Wellness Check: Nutrition

RelatedReports

AAP releases 2016 recommendations for childhood and adolescent immunizations

Public Health

Expanding human papillomavirus vaccination to high-risk mid-adults may be cost-effective

November 26, 2024

Chronic Disease

Radiotherapy with cetuximab or durvalumab for advanced HNSCC

November 18, 2024

Cervical cancer screening practices less cost-effective than suggested guidelines

Chronic Disease

Pembrolizumab with chemoradiotherapy improves survival in locally advanced cervical cancer

October 29, 2024

Lessons from real-world implementation of lung cancer screening

Chronic Disease

Perioperative pembrolizumab improves survival in resectable early-stage non-small cell lung cancer

October 17, 2024

Early palliative care may improve survival in advanced cancer

Fractional carbon dioxide laser not effective for treatment of postmenopausal vaginal symptoms

The Most Outrageous Kim Khasyian Outfits of All Time

Strict tobacco licensing laws linked to reduced adolescent smoking initiation

Smoking prior to open and endovascular revascularization associated with increased post-procedural complications

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result